Does TECLISTAMAB-CQYV Cause Pleural effusion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Pleural effusion have been filed in association with TECLISTAMAB-CQYV. This represents 0.3% of all adverse event reports for TECLISTAMAB-CQYV.
5
Reports of Pleural effusion with TECLISTAMAB-CQYV
0.3%
of all TECLISTAMAB-CQYV reports
2
Deaths
1
Hospitalizations
How Dangerous Is Pleural effusion From TECLISTAMAB-CQYV?
Of the 5 reports, 2 (40.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which TECLISTAMAB-CQYV Alternatives Have Lower Pleural effusion Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL